GN Corporation’s Indian subsidiary Medinippon Healthcare supports the entry of Create Medic into Indian market
Japanese healthcare technology company finds synergy with Indian market and Medinippon’s network April 2 […]
Press release
AIET Cell Therapy based on Japanese Technology Extends Survival and Quality of Life for Cancer Patients, Elevating Vinmec Hospital
Vietnam’s Role in Asian Medical Tourism; NCRM & GN Corporation spearhead tech-transfer October 29, 2025 Co
Thoothukudi Medical College Dermatologists unravel a novel solution for Psoriasis Vulgaris using Neu-REFIX Beta glucan jointly with Japanese scientists.
At the MENA Conference on Rare DiData presented in IFPA 7th World Psoriasis conference, in Stockholm, Sweden 0
Cliny PEG Gastrostomy kits of Create Medic launched in India by Medinippon, GNCorp sister company
Cliny PEG Gastrostomy kits of Create Medic launched in India by Medinippon, GNCorp sister company 11Aug2023 Ja
Increased yield of Beta 1,3-1,6 glucans, produce of AFO-202 strain of Aureobasidium Pullulans, using improvised techniques by Japanese scientists
Japanese scientists, research collaborators to Nichi-in Centre for Regenerative Medicine (NCRM) have reported an increased yield of Beta 1,3-1,6 glucans in the produc
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome Read More »
Autologous immune-cell therapy practiced in Japan, helping Vinmec Hospital after technology transfer
Technology transfer on cell therapy to Vietnam by GN Corporation leads to new opportunities
Webiner on “Cell Therapy Approaches for Urethral Stricture” jointly held with Edogawa Hospital
Webiner on Cell Therapy Approaches for Urethral Stricture is held on 16 OCt 2022
Paper on Potential of Beta-Glucan Products to Prevent and Treat Non-Alcoholic Fatty Liver Disease
A look at the potential of beta-glucan for the growing number of non-alcoholic fatty liver diseases